Prestige 4 Vaccine

Supplied By: Merck (183130)


SKU
061234


Unit of
Measure 1 Dose


Pack
Type Syringe


Case
Qty 10

Login
{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023 Apr- 2023
{{purchaseHistoryItem}}


SKU 061234


Size 1 Dose

Case
Qty 10

Purchase History

Apr- 2024 {{productPurchaseHistory['061234'][0]}} Sep- 2023 {{productPurchaseHistory['061234'][0+7]}}
Mar- 2024 {{productPurchaseHistory['061234'][1]}} Aug- 2023 {{productPurchaseHistory['061234'][1+7]}}
Feb- 2024 {{productPurchaseHistory['061234'][2]}} Jul- 2023 {{productPurchaseHistory['061234'][2+7]}}
Jan- 2024 {{productPurchaseHistory['061234'][3]}} Jun- 2023 {{productPurchaseHistory['061234'][3+7]}}
Dec- 2023 {{productPurchaseHistory['061234'][4]}} May- 2023 {{productPurchaseHistory['061234'][4+7]}}
Nov- 2023 {{productPurchaseHistory['061234'][5]}} Apr- 2023 {{productPurchaseHistory['061234'][5+7]}}
Oct- 2023 {{productPurchaseHistory['061234'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}
Login

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

This product has been shown effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis (EEE and WEE) viruses, equine influenza virus (EIV) and tetanus. Duration of immunity has been shown at 6 months for EIV. Duration of immunity for Eastern and Western encephalomyelitis and tetanus has not been established.

Features & Benefits

  • Provides 6 months of protection against EIV
  • Tetanus, EEE and WEE are core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year.
  • Formulated to minimize reactions and maximize protection
  • All horses are at risk of developing tetanus, an often fatal disease
  • A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07 and tetanus toxoid